(Q37825893)

23 August 2017

1 reference

title

Sex hormones and lipoprotein(a) concentration (English)

1 reference

23 August 2017

0 references

1 reference

Giovanni Gaeta

1

1 reference

23 August 2017

Simona Lanero

2

1 reference

23 August 2017

Silvia Barra

3

1 reference

23 August 2017

Nunzia Silvestri

4

1 reference

23 August 2017

Vittoria Cuomo

5

1 reference

23 August 2017

Crescenzo Materazzi

6

1 reference

23 August 2017

Giancarlo Vitagliano

7

1 reference

23 August 2017

language of work or name

English

0 references

publication date

4 January 2011

1 reference

Expert Opinion on Investigational Drugs

23 August 2017

published in

1 reference

23 August 2017

volume

20

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

221-238

1 reference

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Genetic architecture and evolution of the lipoprotein(a) trait

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Genetically elevated lipoprotein(a) and increased risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Development of antibody against epitope of lipoprotein(a) modified by oxidation: evaluation of new enzyme-linked immunosorbent assay for oxidized lipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Lipoprotein(a): from molecules to therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Effects of estrus cycle, ovariectomy, and treatment with estrogen, tamoxifen, and progesterone on apolipoprotein(a) gene expression in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Molecular definition of the extreme size polymorphism in apolipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

A ligand-induced conformational change in apolipoprotein(a) enhances covalent Lp(a) formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Turnover of lipoprotein (a) in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Expression of a recombinant apolipoprotein(a) in HepG2 cells. Evidence for intracellular assembly of lipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a].

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Apolipoprotein(a) yeast artificial chromosome transgenic rabbits. Lipoprotein(a) assembly with human and rabbit apolipoprotein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

The decline of androgen levels in elderly men and its clinical and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Effects of androgen substitution on lipid profile in the adult and aging hypogonadal male

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Low serum testosterone and mortality in male veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Low serum testosterone and mortality in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Low serum testosterone and increased mortality in men with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Pharmacology of anabolic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Effect of testosterone enanthate on serum lipoproteins in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Testosterone decreases lipoprotein(a) in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Serum lipids in oophorectomized women during estrogen and testosterone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Effects of androgen manipulation on postprandial triglyceridaemia, low-density lipoprotein particle size and lipoprotein(a) in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Molecular characterization of the microsomal tamoxifen binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Multiple targeting by the antitumor drug tamoxifen: a structure-activity study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Reduction of serum lipoprotein (a) by estrogen in men with prostatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Estrogen treatment of prostate cancer increases triglycerides in lipoproteins as demonstrated by HPLC and immunoseparation techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Lipoprotein (a) concentrations in postmenopausal women taking norethisterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Influence of two hormone replacement therapy regimens, oral oestradiol valerate and cyproterone acetate versus transdermal oestradiol and oral dydrogesterone, on lipid metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Effect of hormone replacement therapy on lipids in perimenopausal and early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

A 2-year, randomized, comparative, placebo-controlled study on the effects of raloxifene on lipoprotein(a) and homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Combined oral estradiol valerate-norethisterone treatment over 3 years in postmenopausal women: effect on lipids, coagulation factors, haematology and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

A cross-sectional study of the effects of hormon replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Does the type of hormone replacement therapy affect lipoprotein (a), homocysteine, and C-reactive protein levels in postmenopausal women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Overweight and effect of hormone replacement therapy on lipid profiles in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Effects of toremifene (TOR) and tamoxifen (TAM) on serum lipids in postmenopausal patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Effect of letrozole on the lipid profile in postmenopausal women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Effects of tibolone on lipoprotein(a) and HDL subfractions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

The influence of 5-year therapy with tibolone on the lipid profile in postmenopausal women with mild hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Niacin and lipoprotein(a): facts, uncertainties, and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

High density lipoproteins during hypolipidemic therapy. A comparative study of four drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Effect of tamoxifen on serum lipid metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Androgens in men--uses and abuses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Anabolic steroid abuse and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Testosterone deficiency syndrome: treatment and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Endometrial cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Androgens and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Association of testosterone, insulin-like growth factor-I, and C-reactive protein with metabolic syndrome in Chinese middle-aged men with a family history of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Endogenous sex hormones and progression of carotid atherosclerosis in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Estrogen plus progestin and risk of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Effects of tamoxifen on serum lipid and apolipoprotein levels in postmenopausal patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

Anabolic Androgenic Steroids and Suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

High-affinity anti-oestrogen binding site distinct from the oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.548804

10.1517/13543784.2011.548804

21 January 2018

Identifiers

DOI

1 reference

release_dnaglflfdbgbjb67bhuwzuvjuu

23 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dnaglflfdbgbjb67bhuwzuvjuu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference